Thomas Schlüter

Synthetic Farnesoid X Receptor Agonists Induce High-Density Lipoprotein-Mediated Transhepatic Cholesterol Efflux in Mice and Monkeys and Prevent Atherosclerosis in Cholesteryl Ester Transfer Protein Transgenic Low-Density Lipoprotein Receptor (−/−) Mice

Eva Hambruch, Shinobu Miyazaki‐Anzai, Ulrike K. Hahn et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 99 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model

Ulrich Deuschle, Julia Schüler, Andreas Schulz et al. · PLoS ONE · 2012 · 83 citations · Full text

Medicine, Molecular Biology, Oncology +16

Effects of Implantable Cardioverter Defibrillator Implantation and Shock Application on Biochemical Markers of Myocardial Damage

Thomas Schlüter, H Baum, Andreas Plewan et al. · Clinical Chemistry · 2001 · 70 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists

Ulrich Abel, Thomas Schlüter, Andreas Schulz et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study

John D. Sheppard, David Wirta, Eugene McLaurin et al. · Cornea · 2021 · 56 citations · Full text

Medicine, Ophthalmology, Pharmacology +17